<?xml version="1.0" encoding="ISO-8859-15"?>








<rss version="2.0">
    <channel>
        
        <title>Human Genome Sciences Inc.</title>
        <link>http://www.latimes.com/topic/economy-business-finance/chemical-industry/biotechnology-industry/human-genome-sciences-inc.-ORCRP007477.topic</link>
        
        
        <description>A collection of news and information related to Human Genome Sciences Inc. published by Tribune Company sources.</description>
        
        <language>en-us</language>
        
        
			
			
				
					
					
					
					
		<item>
			<title><![CDATA[Bioterrorism consultant's anthrax claims challenged]]></title>
			
			

			
			<link>http://www.latimes.com/topic/na-anthrax-aum-20130522-m,0,165309.story?track=rss-topicgallery</link>
				
			
			<pubDate>2013-05-22 15:07:00</pubDate>
            <description><![CDATA[WASHINGTON &mdash; As an example of the ease with which terrorists could produce anthrax, former Navy Secretary Richard J. Danzig has repeatedly cited the Japanese cult Aum Shinrikyo. 

The cult gained infamy in 1995 by unleashing the nerve agent sarin in...]]></description>
		</item>
				
					
					
					
					
		<item>
			<title><![CDATA[Spotlighting a terrorism risk, and profiting]]></title>
			
			

			
			<link>http://www.latimes.com/topic/na-anthrax-resistant-20130519-m,0,4966939.story?track=rss-topicgallery</link>
				
			
			<pubDate>2013-05-19 00:00:00</pubDate>
            <description><![CDATA[WASHINGTON &mdash; Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he...]]></description>
		</item>
				
					
					
					
					
		<item>
			<title><![CDATA[GlaxoSmithKline to pay $3 billion healthcare fraud settlement, U.S. says]]></title>
			
			

			
			<link>http://www.latimes.com/topic/la-fi-mo-glaxosmithkline-settlement-20120702,0,7074612.story?track=rss-topicgallery</link>
				
			
			<pubDate>2012-07-02 10:35:00</pubDate>
            <description><![CDATA[Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...]]></description>
		</item>
				
					
					
					
					
		<item>
			<title><![CDATA[Lupus drug Benlysta passes second crucial test]]></title>
			
			

			
			<link>http://www.latimes.com/topic/la-fi-mo-glaxosmithkline-settlement-20120702,0,7074612.story?track=rss-topicgallery</link>
				
			
			<pubDate>2009-11-02 16:32:29</pubDate>
            <description><![CDATA[Pharmaceutical drug maker GlaxoSmithKline will pay $3 billion and plead guilty to federal charges to resolve a slew of criminal and civil issues stemming from its use of kickbacks, mis-branding and other misconduct to market drugs such as Paxil,...]]></description>
		</item>
				
					
					
					
					
		<item>
			<title><![CDATA[Pointing to threat, pulling in profit]]></title>
			
			

			
			<link>http://www.latimes.com/topic/chi-anthrax-resistant-20130519,0,2474274.story?track=rss-topicgallery</link>
				
			
			<pubDate>2013-05-19 08:22:00</pubDate>
            <description><![CDATA[WASHINGTON -- Over the last decade, former Navy Secretary Richard J. Danzig, a prominent lawyer, presidential advisor and biowarfare consultant to the Pentagon and the Department of Homeland Security, has urged the government to counter what he called a...]]></description>
		</item>
				
					
					
					
					
		<item>
			<title><![CDATA[Report: Bio-warfare adviser warned US of threat of new anthrax while on board of drug maker]]></title>
			
			

			
			<link>http://www.latimes.com/topic/sns-ap-us-bio-warfare-adviser-anthrax-drug-20130519,0,1431467.story?track=rss-topicgallery</link>
				
			
			<pubDate>2013-05-20 00:45:04</pubDate>
            <description><![CDATA[WASHINGTON (AP) &#8212; Former Navy Secretary Richard J. Danzig, who has served as a bio-warfare adviser to the president, the Pentagon, and the Department of Homeland Security, urged the government to stockpile an anti-anthrax drug while serving as a...]]></description>
		</item>
				
					
					
					
					
		<item>
			<title><![CDATA[Timeline: An attorney and anthrax]]></title>
			
			

			
			<link>http://www.latimes.com/topic/chi-anthrax-resistant-timeline-20130519,0,2263980.story?track=rss-topicgallery</link>
				
			
			<pubDate>2013-05-19 05:56:00</pubDate>
            <description><![CDATA[May 2001: Washington lawyer Richard J. Danzig is appointed to the board of Human Genome Sciences Inc. in Rockville, Md. 

Sept. 11, 2001: Terrorists crash passenger jets into the World Trade Center in New York, the Pentagon and rural Pennsylvania. Soon...]]></description>
		</item>
				
					
					
					
					
		<item>
			<title><![CDATA[Human Genome to lay off 97 workers]]></title>
			
			

			
			<link>http://www.latimes.com/topic/bs-bz-human-genome-layoffs-20121017,0,194367.story?track=rss-topicgallery</link>
				
			
			<pubDate>2012-10-17 15:19:00</pubDate>
            <description><![CDATA[Human Genome Sciences Inc., which was acquired for $3.6 billion by London-based GlaxoSmithKline Plc in August, intends to lay off 97 employees in mid-December, and an additional but unspecified number of cuts are planned for next year, the company...]]></description>
		</item>
				
					
					
					
					
		<item>
			<title><![CDATA[Human Genome Sciences announces plan to lay off 114]]></title>
			
			

			
			<link>http://www.latimes.com/topic/bs-bz-human-genome-layoffs-20120905,0,1439556.story?track=rss-topicgallery</link>
				
			
			<pubDate>2012-09-05 12:45:00</pubDate>
            <description><![CDATA[Rockville-based Human Genome Sciences has warned state regulators that it plans to cut 114 jobs beginning in October, three months after striking a deal to be acquired by GlaxoSmithKline.

Human Genome, which employs about 1,000 people in Rockville, could...]]></description>
		</item>
				
					
					
					
					
		<item>
			<title><![CDATA[GlaxoSmithKline to acquire Human Genome Sciences]]></title>
			
			

			
			<link>http://www.latimes.com/topic/bs-bz-gsk-buys-hgs-20120716,0,540191.story?track=rss-topicgallery</link>
				
			
			<pubDate>2012-07-16 16:00:36</pubDate>
            <description><![CDATA[After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.

GlaxoSmithKline boosted its offer for...]]></description>
		</item>
				
					
					
					
					
		<item>
			<title><![CDATA[Ripley's opens Odditorium at Harborplace]]></title>
			
			

			
			<link>http://www.latimes.com/topic/bs-bz-digest-0609-20120608,0,3784601.story?track=rss-topicgallery</link>
				
			
			<pubDate>2012-06-08 13:54:54</pubDate>
            <description><![CDATA[Ripley's Believe It or Not, one of the first of several new tenants opening for the summer tourist season at Harborplace in downtown Baltimore, will open Saturday in the Light Street Pavilion.

Ripley Entertainment Inc. said exhibits at the Inner Harbor...]]></description>
		</item>
				
					
					
					
					
		<item>
			<title><![CDATA[Consolidation wave poised to hit state's health care services, biopharma sectors]]></title>
			
			

			
			<link>http://www.latimes.com/topic/bs-bz-human-genome-catalyst-20120420,0,7682750.story?track=rss-topicgallery</link>
				
			
			<pubDate>2012-04-21 11:26:07</pubDate>
            <description><![CDATA[Like a one-two punch, two major Maryland employers in the health care service and pharmaceutical industries were the targets last week of multibillion-dollar acquisition deals.

Both homegrown companies &#8212; Human Genome Sciences Inc. and Catalyst...]]></description>
		</item>
				
			
			
        

        
			
				
				
					
					
						
						
							
						
						
						
						
						
						
							
							
		<item>
			<title><![CDATA[A bottle of Xenical, a weight-loss aid made by GlaxoSmithKline. The company is making a hostile bid for Human Genome Sciences.]]></title>
			<link>http://www.latimes.com/topic/la-fi-mo-glaxo-human-genome-20120509-001,0,6737421.photo?track=rss-topicgallery
			</link>
			<pubDate>2012-05-09 00:00:00</pubDate>
			<description>&lt;img src="http://www.trbimg.com/img-4faaa141/turbine/la-fi-mo-glaxo-human-genome-20120509-001/187/16x9" alt="GlaxoSmithKline launches hostile tender offer for Human Genome Sciences" width="75" height="42" title="GlaxoSmithKline launches hostile tender offer for Human Genome Sciences" &gt;</description>
		</item>
						
					
					
				
					
					
						
						
							
						
						
						
						
						
						
							
							
		<item>
			<title><![CDATA[Steven C. Mayer, Human Genome Sciences' chief financial officer, in front of building being leased in Rockville. The biotechnology company has been able to preserve its cash by leasing buildings instead of owning them.]]></title>
			<link>http://www.latimes.com/topic/bal-bzphoto112402,0,3215539.photo?track=rss-topicgallery
			</link>
			<pubDate>2002-11-23 07:59:41</pubDate>
			<description>&lt;img src="http://www.baltimoresun.com/media/thumbnails/photo/2002-11/5569038.jpg" alt="Steven C. Mayer" width="66" height="75" title="Steven C. Mayer" &gt;</description>
		</item>
						
					
					
				
			
        
    </channel>
</rss>

